The diagnostic ability of the Japanese version of the high bleeding risk (J-HBR) criteria in patients with lower extremity peripheral arterial disease remains unclear.
Does the Japanese version of the high bleeding risk (J-HBR) criteria predict major bleeding and ischemic events in patients with lower extremity arterial disease undergoing endovascular treatment?
The J-HBR criteria successfully stratifies ischemic risk, though not significantly for bleeding risk, in Japanese patients with lower extremity arterial disease undergoing endovascular treatment.
Absolute Event Rate: 0% vs 0%
Background: The Japanese version of the high bleeding risk (J-HBR) criteria was proposed to identify Japanese patients at HBR after percutaneous coronary intervention. However, the diagnostic ability of the J-HBR in patients with lower extremity peripheral arterial disease (LEAD) remains unclear.
Matsumoto et al. (Tue,) reported a other. The diagnostic ability of the Japanese version of the high bleeding risk (J-HBR) criteria in patients with lower extremity peripheral arterial disease remains unclear.